The BfArM issues information on the initiation of a European safety review according to Article 31 of Directive 2001/83/EC. This procedure was initiated at the request of the Belgian Federal Agency for Medicines and Health Products.

To the risk assessment procedure (available in German only)

For details regarding the procedure please click on the following link to the European Medicines Agency (EMA):